Qiagen NV (NYSE: QGEN) shares are trading higher on Friday after Deutsche Bank upgraded the stock from Hold to Buy and raised its price target on the stock from $32 to $60 per share.Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and protein...